Organization
Merck & Co., Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Merck & Co., Inc.
... of Zesty, Juha Paananen of NonStop Games, and Junaid Bajwa of Merck & Co participated in the round, among others. Quit Genius was built by ...
... Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced ...
... doses of a vaccine candidate, known as rVSV-ZEBOV, which is offered by Merck. The vaccine is not fully licensed but is available for "compassionate use" ...
... Dr. Dansey brings extensive experience in cancer drug development, most recently from Merck Inc. where he was Therapeutic Area Head for Late Stage Oncology, responsible ...
... Ib/II clinical study (Study 111) of lenvatinib in combination with the Merck Co., Inc., Kenilworth, N.J., U.S.A. (known as MSD outside the United States and ...
... and lack of roads. Because it is not yet licensed, the Merck & Co vaccine has been offered to Congo under a "compassionate use" protocol ...
... in Alzheimer’s disease. The news comes just a few weeks after Merck & Co. abandoned a second phase 3 trial of its BACE inhibitor candidate ...
... a $200 million patent damages verdict against client Gilead Sciences after proving Merck had forfeited its right to assert its hepatitis C drug patents against ...
... 1.1% 18 Lowe's Companies, Inc. 1.1% 19 Chubb Ltd. 1.0% 20 Merck & Co., Inc. 1.0% Holdings are subject to change. Monthly Performance: Beginning of ...
... 1.1% 18 Lowe's Companies, Inc. 1.1% 19 Chubb Ltd. 1.0% 20 Merck & Co., Inc. 1.0% Holdings are subject to change. Monthly Performance: Beginning of ...
Subscribe now for full coverage on Merck & Co., Inc.
Start My Free Trial